EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rational Computational Approaches in Drug Discovery: Potential Inhibitors for Allosteric Regulation of Mutant Isocitrate Dehydrogenase-1 Enzyme in Cancers

Masthan Thamim iD, Ashish Kumar Agrahari, Pawan Gupta iD, Krishnan Thirumoorthy iD

Molecules · 2023

DOI: 10.3390/molecules28052315 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Masthan Thamim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, School of Advanced Sciences, Vellore Institute of Technology, Vellore 632014, Tamil Nadu, India. Hauptthemen laut MEDLINE: Isocitrate Dehydrogenase, Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Science and Technology, Department of Science and Technology (DST) India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mutations in homodimeric isocitrate dehydrogenase (IDH) enzymes at specific arginine residues result in the abnormal activity to overproduce D-2 hydroxyglutarate (D-2HG), which is often projected as solid oncometabolite in cancers and other disorders. As a result, depicting the potential inhibitor for D-2HG formation in mutant IDH enzymes is a challenging task in cancer research. The mutation in the cytosolic IDH1 enzyme at R132H, especially, may be associated with higher frequency of all types of cancers. So, the present work specifically focuses on the design and screening of allosteric site binders to the cytosolic mutant IDH1 enzyme. The 62 reported drug molecules were screened along with biological activity to identify the small molecular inhibitors using computer-aided drug design strategies. The designed molecules proposed in this work show better binding affinity, biological activity, bioavailability, and potency toward the inhibition of D-2HG formation compare to the reported drugs in the in silico approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Isocitrate DehydrogenaseNeoplasmsHumansAllosteric RegulationGlutaratesMutationDrug DiscoveryEnzyme Inhibitors

Stichwörter der Autor:innen

2-Hydroxyglutarate3D-QSARADMECADDcancerschiralitydrug discoveryepigeneticsinhibitorsmolecular dockingmolecular dynamics simulationoncometabolite

Substanzen

Isocitrate Dehydrogenasealpha-hydroxyglutarateGlutaratesEnzyme Inhibitors

Autor:innen und Institutionen

  • Department of Chemistry, School of Advanced Sciences, Vellore Institute of Technology, Vellore 632014, Tamil Nadu, India.
  • Translational Health Science and Technology Institute, Faridabad 121001, Haryana, India.
  • Department of Pharmaceutical Chemistry, Shri Vile Parle Kelavani Mandal's Institute of Pharmacy, Dhule 424001, Maharashtra, India.

ORCID-Profile: Masthan Thamim, Pawan Gupta, Krishnan Thirumoorthy

Förderung

  • Department of Science and Technology
  • Department of Science and Technology (DST) India

Zitieren

APA

Thamim, M., Agrahari, A. K., Gupta, P., & Thirumoorthy, K. (2023). Rational Computational Approaches in Drug Discovery: Potential Inhibitors for Allosteric Regulation of Mutant Isocitrate Dehydrogenase-1 Enzyme in Cancers. Molecules. https://doi.org/10.3390/molecules28052315

Vancouver

Thamim M, Agrahari AK, Gupta P, Thirumoorthy K. Rational Computational Approaches in Drug Discovery: Potential Inhibitors for Allosteric Regulation of Mutant Isocitrate Dehydrogenase-1 Enzyme in Cancers. Molecules. 2023. doi:10.3390/molecules28052315

BibTeX
@article{Thamim2023,
  author = {Thamim, Masthan and Agrahari, Ashish Kumar and Gupta, Pawan and Thirumoorthy, Krishnan},
  title = {Rational Computational Approaches in Drug Discovery: Potential Inhibitors for Allosteric Regulation of Mutant Isocitrate Dehydrogenase-1 Enzyme in Cancers},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28052315}
}
Kostenlos starten →